GSK (LSE:GSK) secured Chinese approval for Exdensur for severe asthma patients aged 12 and older. The company also had its ...

GSK (LSE:GSK) has received FDA approval for Lynavoy (linerixibat), the first treatment in the US for cholestatic pruritus in ...

Learn about the GSK IMPACT Awards winners in 2026 and how they are making a significant impact on their communities.

GSK (GSK.L) on Monday unveiled regulatory updates for its drug portfolio in China, with its asthma medication Exdensur approved and its chronic hepatitis B treatment bepirovirsen accepted for review.

GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

GlaxoSmithKline ( (GB:GSK) ) just unveiled an announcement.

Pharma giant GSK (NYSE:GSK) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Pharma giant GSK (NYSE:GSK) ...

GSK (GSK) stock is in focus as the company wins FDA nod for Lynavoy, the first U.S. treatment for cholestatic pruritus in ...

GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment ...

Samsung Biologics, the biotech arm of Samsung Group, said Wednesday it has acquired a U.S. manufacturing facility from ...

Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...